Eli Shani

Eli Shani was appointed Executive Vice President, Global Marketing and Portfolio in 2021.

The Global Marketing & Portfolio function is responsible for maximizing the value of Teva’s generic, biosimilar and specialty portfolio across the company’s commercial regions, including brokering business development opportunities. The group oversees the interconnections between commercial markets, R&D, operations and external partners through all product lifecycle stages.

Eli served as Senior Vice President of Business Development at Teva since 2018 and assumed additional responsibility for Alliance Management early in 2021 prior to being appointed leader of Teva’s Global Marketing & Portfolio organization and joining the company’s Executive Management team later in 2021.

Prior to that, Eli held several senior leadership roles at Teva including Senior Vice President, Strategic Initiatives, International Markets; Chief Operating Officer of a joint venture formed by Teva and Procter & Gamble; and Vice President in Teva's Corporate Business Development group.

Before joining Teva, Eli was Chief Financial Officer and head of business development at a medical diagnostics company, and prior to that, he held leadership roles in finance and banking with CIBC World Markets and Credit Suisse.

He holds a joint degree in law and accounting from the University of Tel Aviv and an MBA from the University of Chicago.